Evidence map›Paper›PMID 10518536›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1999

Role of the integrin-associated protein CD9 in binding between sperm ADAM 2 and the egg integrin alpha6beta1: implications for murine fertilization.

M S Chen, K S Tung, S A Coonrod, Y Takahashi, D Bigler, A Chang, Y Yamashita, P W Kincade, J C Herr, J M White

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed
5.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 220 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Role of Integrins in Sperm Activation and Fertilization.International journal of molecular sciences · 2021
    Review
  10. Article
  11. Review
  12. Review
  13. CD9, a tetraspanin target for cancer therapy?Experimental biology and medicine (Maywood, N.J.) · 2021
    Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

M S ChenDepartment of Cell Biology, University of Virginia, Charlottesville, VA 22908, USA.
K S Tung
S A Coonrod
Y Takahashi
D Bigler
A Chang
Y Yamashita
P W Kincade
J C Herr
J M White
Oklahoma Medical Research Foundation · USUniversity of Virginia · USState University of New York · USStony Brook University · US

Funding

PROJECT 3 - Steroid-Metabolic Interactions In the Control of GnRH NeuronsU54HD028934 · NICHD · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI HAISENLEDER, DANIEL J. · 1998 to 2013
$16.5M
PROTEIN IMMUNOGENS OF THE HUMAN SPERM SURFACEU54HD029099 · NICHD · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI HERR, JOHN C · 1991 to 2004
$6.2M
MOLECULAR MECHANISMS OF CELL/CELL FUSION PROTEINSR01GM048739 · NIGMS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI WHITE, JUDITH M. · 1993 to 2004
$1.6M
NICHD NIH HHS U54 HD028934NICHD NIH HHS U54 HD029099NICHD NIH HHS U54 HD 28934NICHD NIH HHS U54 HD 29099NIGMS NIH HHS GM48739NIGMS NIH HHS R01 GM048739
6 · The paper itself

Abstract

CD9 is a tetraspan protein that associates with several beta1 integrins, including alpha6beta1. Because alpha6beta1 is present on murine eggs and interacts with the sperm-surface glycoprotein ADAM 2 (fertilin beta), we first asked whether CD9 is present on murine eggs and whether it functions in sperm-egg binding and fusion. CD9 is present on the plasma membrane of oocytes in the ovary as well as on eggs isolated from the oviduct. The anti-CD9 mAb, JF9, potently inhibits sperm-egg binding and fusion in vitro in a dose-dependent manner. JF9 also disrupts binding of fluorescent beads coated with native fertilin or a recombinant fertilin beta disintegrin domain. (Both ligands bind to the egg via alpha6beta1.) Immunohistochemistry showed that CD9 is undetectable in the uterine epithelium, appears basolaterally and as prominent apical patches on the epithelium in the region between the uterus and the oviduct, and then persists apically in the oviduct. The integrin alpha6A subunit is found in similar apical patches in the region between the uterus and oviduct, but is confined to the basal aspect of the epithelium in the uterus and oviduct. Hence, alpha6A and CD9 both are expressed on the apical epithelial surface at the uterine-oviduct junction. These findings correlate with the observation that fertilin beta "knockout" sperm traverse the uterus but do not progress into the oviduct, contributing to the infertility of fertilin beta(-/-) male mice. Our results suggest that high-avidity binding between fertilin beta (ADAM 2) and alpha6beta1 requires cooperation between alpha6beta1 and CD9. Such cooperation may assist sperm passage into the oviduct as well as sperm-egg interactions.

Indexed as

FertilizationADAM ProteinsAnimalsAntigens, CDFemaleFertilinsImmunohistochemistryIntegrin alpha6beta1IntegrinsMaleMembrane GlycoproteinsMetalloendopeptidasesMiceMice, Inbred C57BLMice, Inbred ICRModels, BiologicalAdam2 protein, mouseADAM ProteinsAntigens, CDCd9 protein, mouseFertilinsIntegrin alpha6beta1IntegrinsMembrane GlycoproteinsMetalloendopeptidasesTetraspanin 29

Identifiers

PMID10518536
PMCPMC18372
OpenAlexW2168108725

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.